365 Whole Foods Market Guaifenesin NDC 42681-0057

Product information

Brand name (proprietary)

365 Whole Foods Market Guaifenesin

Generic name (nonproprietary)

guaifenesin

Active ingredients

Guaifenesin — 600 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Whole Foods Market, Inc.

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210453

Marketing start

Jan 23, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Respiratory Secretion Viscosity (Physiologic effect)Increased Respiratory Secretions (Physiologic effect)

Identifiers

Product ID 42681-0057_7c890031-8188-48be-bb69-06db0e01a0c0SPL ID 7c890031-8188-48be-bb69-06db0e01a0c0SPL set ID 7c890031-8188-48be-bb69-06db0e01a0c0RxCUI 636522UNII 495W7451VQUPC 0099482547868

Pharmacologic class

Expectorant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442681005701 followed by a unit qualifier and the quantity Copy

Package 42681-0057-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 210453

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.